AMACR and neoplasm: One prevailing hypothesis posits that AMACR functions as a gatekeeper of β-oxidation, and that its overexpression enables PCa cells to shift their metabolic reliance toward FA β-oxidation, thereby supporting tumor progression [109,111,114].